204 related articles for article (PubMed ID: 29789426)
1. JAK1-mediated Sirt1 phosphorylation functions as a negative feedback of the JAK1-STAT3 pathway.
Wang W; Li F; Xu Y; Wei J; Zhang Y; Yang H; Gao B; Yu G; Fang D
J Biol Chem; 2018 Jul; 293(28):11067-11075. PubMed ID: 29789426
[TBL] [Abstract][Full Text] [Related]
2. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation.
Sestito R; Madonna S; Scarponi C; Cianfarani F; Failla CM; Cavani A; Girolomoni G; Albanesi C
FASEB J; 2011 Mar; 25(3):916-27. PubMed ID: 21098725
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling.
Rutherford C; Speirs C; Williams JJ; Ewart MA; Mancini SJ; Hawley SA; Delles C; Viollet B; Costa-Pereira AP; Baillie GS; Salt IP; Palmer TM
Sci Signal; 2016 Nov; 9(453):ra109. PubMed ID: 27919027
[TBL] [Abstract][Full Text] [Related]
4. JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.
Song L; Rawal B; Nemeth JA; Haura EB
Mol Cancer Ther; 2011 Mar; 10(3):481-94. PubMed ID: 21216930
[TBL] [Abstract][Full Text] [Related]
5. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
[TBL] [Abstract][Full Text] [Related]
6. CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling.
Zhang WN; Wang L; Wang Q; Luo X; Fang DF; Chen Y; Pan X; Man JH; Xia Q; Jin BF; Li WH; Li T; Liang B; Chen L; Gong WL; Yu M; Li AL; Zhou T; Li HY
J Biol Chem; 2012 Jan; 287(1):382-392. PubMed ID: 22084247
[TBL] [Abstract][Full Text] [Related]
7. PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation.
Meares GP; Liu Y; Rajbhandari R; Qin H; Nozell SE; Mobley JA; Corbett JA; Benveniste EN
Mol Cell Biol; 2014 Oct; 34(20):3911-25. PubMed ID: 25113558
[TBL] [Abstract][Full Text] [Related]
8. Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS.
Kurdi M; Booz GW
J Cell Physiol; 2007 Aug; 212(2):424-31. PubMed ID: 17385713
[TBL] [Abstract][Full Text] [Related]
9. [Regulatory effect of resveratrol on JAK1/STAT3 signal transduction pathway in leukemia].
Li T; Wang W; Li T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):772-6. PubMed ID: 18718058
[TBL] [Abstract][Full Text] [Related]
10. Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation.
Liu KD; Gaffen SL; Goldsmith MA; Greene WC
Curr Biol; 1997 Nov; 7(11):817-26. PubMed ID: 9382798
[TBL] [Abstract][Full Text] [Related]
11. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
[TBL] [Abstract][Full Text] [Related]
12. IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells.
Kopantzev Y; Heller M; Swaminathan N; Rudikoff S
Oncogene; 2002 Oct; 21(44):6791-800. PubMed ID: 12360405
[TBL] [Abstract][Full Text] [Related]
13. Baicalin regulates SirT1/STAT3 pathway and restrains excessive hepatic glucose production.
Xu J; Li Y; Lou M; Xia W; Liu Q; Xie G; Liu L; Liu B; Yang J; Qin M
Pharmacol Res; 2018 Oct; 136():62-73. PubMed ID: 30144531
[TBL] [Abstract][Full Text] [Related]
14. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
15. LIF-JAK1-STAT3 signaling delays contact inhibition of human corneal endothelial cells.
Liu X; Tseng SC; Zhang MC; Chen SY; Tighe S; Lu WJ; Zhu YT
Cell Cycle; 2015; 14(8):1197-206. PubMed ID: 25695744
[TBL] [Abstract][Full Text] [Related]
16. Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway.
Tang LY; Heller M; Meng Z; Yu LR; Tang Y; Zhou M; Zhang YE
J Biol Chem; 2017 Mar; 292(10):4302-4312. PubMed ID: 28154170
[TBL] [Abstract][Full Text] [Related]
17. Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation.
Kim SM; Kwon OJ; Hong YK; Kim JH; Solca F; Ha SJ; Soo RA; Christensen JG; Lee JH; Cho BC
Mol Cancer Ther; 2012 Oct; 11(10):2254-64. PubMed ID: 22891040
[TBL] [Abstract][Full Text] [Related]
18. Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity.
Andrés RM; Hald A; Johansen C; Kragballe K; Iversen L
Exp Dermatol; 2013 May; 22(5):323-8. PubMed ID: 23614738
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells.
Niculescu F; Soane L; Badea T; Shin M; Rus H
Immunopharmacology; 1999 May; 42(1-3):187-93. PubMed ID: 10408379
[TBL] [Abstract][Full Text] [Related]
20. Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3.
Kim NH; Lee MY; Park SJ; Choi JS; Oh MK; Kim IS
Immunology; 2007 Dec; 122(4):607-14. PubMed ID: 17645497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
